Augustin Matthias, Brignone Mélanie
Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Market Access and Health Economics and Outcomes Research, Pierre Fabre, Boulogne-Billancourt, France.
Int J Dermatol. 2025 Jun;64 Suppl 1(Suppl 1):53-57. doi: 10.1111/ijd.17791.
Topical emollients are the mainstay of basic therapy for managing xerosis cutis (dry skin). In general, most emollient formulations are safe and effective for xerosis cutis and diseases associated with dry skin; however, several other factors can vary widely between products, influence patient adherence, and ultimately affect treatment success. This article reviews key practical and clinical considerations when prescribing emollients for xerosis cutis and discusses strategies to optimize treatment and clinical outcomes for these patients. Although the optimal quantity and frequency of emollient use depend on the extent and severity of skin dryness, frequent (i.e., up to several times daily) and liberal application (i.e., up to 600 g/week) are generally recommended. Lipid-rich ointments are indicated for very dry skin, while hydrophilic creams and lotions are suitable for less severe xerosis cutis; however, treatment decisions should also be guided by other factors (e.g., cosmetic acceptability and practicality) to ensure that patients can adhere to long-term emollient therapy. Strategies to promote shared decision-making and improve treatment adherence include patient education, allowing patients to trial a range of emollient products, regularly following-up with patients, and adjusting treatment to suit their preferences. Emollient therapy is a cost-effective strategy to manage patients with chronic dry skin conditions; however, access to basic, lower-cost formulations remains important to minimize the financial burden on patients. Overall, treatment effectiveness and clinical need should be balanced with individual patient preferences to ensure that the full benefits of emollient therapy for xerosis cutis are realized.
外用润肤剂是治疗皮肤干燥症(干性皮肤)基础疗法的主要手段。一般来说,大多数润肤剂配方对于皮肤干燥症以及与干性皮肤相关的疾病是安全有效的;然而,其他几个因素在不同产品之间差异很大,会影响患者的依从性,并最终影响治疗效果。本文回顾了为皮肤干燥症开处润肤剂时的关键实践和临床考量,并讨论了优化这些患者治疗及临床效果的策略。尽管润肤剂使用的最佳量和频率取决于皮肤干燥的程度和严重程度,但通常建议频繁使用(即每天数次)并大量涂抹(即每周高达600克)。富含脂质的软膏适用于非常干燥的皮肤,而亲水性乳膏和洗剂适用于不太严重的皮肤干燥症;然而,治疗决策也应受其他因素(如美容可接受性和实用性)的指导,以确保患者能够坚持长期使用润肤剂治疗。促进共同决策和提高治疗依从性的策略包括患者教育、让患者试用一系列润肤剂产品、定期对患者进行随访以及根据患者偏好调整治疗方案。润肤剂疗法是管理慢性干性皮肤疾病患者的一种具有成本效益的策略;然而,获得基本的、低成本的配方仍然很重要,以尽量减轻患者的经济负担。总体而言,应在治疗效果和临床需求与患者个人偏好之间取得平衡,以确保实现润肤剂疗法对皮肤干燥症的全部益处。